Sepsis is a medical emergency. Early identification and treatment are essential but many health staff are unable to recognise its signs and symptoms
In this article…
- Anatomy of sepsis
- Signs and symptoms that can help professionals identify sepsis
- Effective sepsis management strategies
Heather McClelland is nurse consultant in emergency care, Alex Moxon is emergency department staff nurse; both at Calderdale and Huddersfield Foundation Trust.
McClelland H, Moxon A (2014) Early identification and treatment of sepsis. Nursing Times; 110: 4, 14-17.
Sepsis is a potentially fatal condition and is becoming increasingly frequent, yet health professionals are often unable to recognise its symptoms. It is the body’s exaggerated response to infection and, if left untreated, will lead to severe sepsis, multi-organ failure and death. Nurses play a vital role in identifying patients with sepsis and starting essential treatment. This article looks at how sepsis can be identified and effectively treated to improve survival.
- This article has been double-blind peer reviewed
- Figures and tables can be seen in the attached print-friendly PDF file of the complete article in the ‘Files’ section of this page
5 key points
- Sepsis is one of the leading causes of death in hospital patients worldwide
- Patients with severe sepsis will not respond to fluid replacement
- Sepsis can be identified during routine observations so nurses play a vital role in spotting symptoms
- All patients with sepsis should have a management plan that includes level of observation, review schedule and an escalation plan
- Clear guidance on identification and evidence-based interventions is available to support effective and safe care
Sepsis is one of the leading causes of death in hospital patients worldwide and severe sepsis causes around 37,000 deaths in the UK every year (Daniels, 2011). This is more than breast and bowel cancer combined, yet awareness of the condition remains limited. Despite various campaigns and the availability of good evidence for treatment, the death rate associated with sepsis remains high, mainly due to poor identification and delayed interventions.
Defined as “a life-threatening condition that arises when the body’s response to infection injures its own tissues and organs” (Czura, 2011), sepsis can present in any patient and in any clinical setting. As such, all nurses need to be aware of its development, how it can be identified and the care patients need to survive. This article discusses the pathophysiological changes caused by sepsis, how these present in patients and how best to manage sepsis to prevent death or long-term disability.
Chege and Cronin (2007) described early evidence of treatment for sepsis as existing as far back as the early Chinese emperors. However, it was not until 1991 that definitions of sepsis were agreed and later published (Box 1) (Bone et al, 1992). These underpin more recent research and guidance from leading campaign groups such as the Surviving Sepsis Campaign (SSC) and Global Sepsis Alliance. SSC - a partnership of international critical care, medical and emergency care societies - aims to raise awareness and provide guidance based on the best available evidence. In the UK, SSC guidance is being changed to improve both the identification of patients at risk of developing severe sepsis and the delivery of early treatment.
What is sepsis?
Although sepsis is mainly caused by bacterial infection, it can be caused by a viral, fungal or even parasitic source (Fig 1). As the infection affects the body’s normal inflammatory response, physiological changes can be seen that aid diagnosis.
Systemic inflammatory response syndrome (SIRS) is a collection of signs that the body is reacting to a range of injuries or illnesses (Box 2), and is not specific to infection. The body may respond by raising the heart or respiratory rate to increase the amount of oxygen - by altering body temperature or increasing white cell production - to overcome infection. Raised blood sugars and new confusion or an altered mental state may be early signs of metabolic stress or hypoxia (Survive Sepsis Organisation, 2009). Although these responses can have a range of causes, when combined with infection, they could indicate sepsis. The condition is defined by the presence of two or more SIRS signs where infection is suspected or confirmed (Woodrow, 2012).
Sepsis causes complex dysfunction in the body’s inflammatory and coagulopathy pathways, leading to vasodilatation, vessel leakage and increased metabolic demands. This effect increases oxygen demand which, combined with intravascular losses, causes hypoperfusion and ischaemia at cellular levels (Porth, 2005). At this stage, there will be signs of severe sepsis and evidence of organ dysfunction away from the primary source of infection (Box 3).
In a patient with sepsis from a urinary tract infection, some changes to renal function might be expected, but not abnormal blood clotting or lactate levels. Low blood pressure and dehydration is commonly seen in patients with sepsis, but will generally respond to fluid replacement. Patients with severe sepsis who do not respond to this treatment are in septic shock. If not actively managed, this leads to refractory hypotension, tissue ischaemia, circulatory collapse and multi-organ failure.
Patients at greatest risk of sepsis often have multiple comorbidities so treatment needs to be considered carefully. For example, patients with chronic respiratory disease presenting with a chest infection may have abnormal vital signs because of their long-term condition or because they have developed sepsis and may not tolerate high-flow oxygen as part of the sepsis treatment protocol.
Identification of sepsis
Identifying sepsis early is key to survival but is still the greatest challenge facing effective sepsis management (Slade et al, 2003). By undertaking routine clinical observations, nurses play a vital role in identifying sepsis. Any patient presenting with two or more SIRS and a suspected infective source is deemed to have sepsis and needs further screening for signs of organ dysfunction (severe sepsis) and risk of mortality.
Simple screening tools are widely used to identify patients with sepsis (Fig 2). Some organisations have successfully implemented routine screening of all admissions; others screen in the emergency department. It is important to remember that SIRS is not always caused by infection and may be present for a range of medical reasons. Good clinical assessment, history taking and investigation will ensure accurate diagnosis and help to estimate the severity of the illness.
Certain populations are at greater risk of sepsis and should be more closely assessed and monitored for deterioration. Young children, frail older people or those with multiple comorbidities may not have the same capacity to fight infection as the general population. Those with long-term invasive devices, such as urinary catheters or cannulae, are equally at risk. Chemotherapy and other anti-cancer treatments increase the risk of neutropenic sepsis so this should be considered in all patients who become unwell following these treatments (National Institute for Health and Clinical Excellence, 2012). National early warning scores (Royal College of Physicians, 2012) and robust escalation protocols help identify and manage deterioration. Nurses need to understand what resources are available in their organisation to help identify patients whose health is deteriorating.
The majority of research evidence on sepsis is limited to severe sepsis and septic shock - there is little on uncomplicated sepsis. Patients with sepsis need immediate intervention to determine severity and prevent deterioration to severe sepsis.
The use of care bundles is recommended by the SSC and other international sepsis forums. Care bundles bring together a small number of interventions that, when undertaken together and reliably, improve patient outcomes (Institute for Healthcare Improvement, 2012). SSC guidance presents two bundles for severe sepsis and septic shock, with actions to be delivered within three hours and six hours of identification (previously known as the “Resuscitation and Management bundles”) (Dellinger et al, 2013). Daniels et al (2010) note that, although the SSC bundles are internationally recognised, they have elements that require critical-care skills that are not always available in emergency departments or acute medical units (AMUs), where they are most likely to be started. McNeill et al (2008) found that few AMUs in the UK were able to resuscitate patients using the SSC care bundles.
Daniels et al (2010) developed the “Sepsis Six” care bundle, which was shown to improve delivery of reliable care across a range of clinical settings; endorsed by the College of Emergency Medicine and the SSC, it is now used in many UK hospitals. Sepsis Six (Box 4) consists of three investigations and three interventions that all patients with sepsis should receive within one hour of identification. Most of the actions can be started by nursing staff while waiting for a medical response, and aid prompt, effective decision-making. All patients with severe sepsis should be reviewed by critical care staff for further interventions.
Each element of the Sepsis Six bundle can create a significant challenge for clinical teams so it is worth looking at each in detail. Staff should review each element and reflect on its implication in everyday practice. Organisations may use the Sepsis Six approach or have their own protocols so it is important to check local policies.
Bloods (including lactate)
If sepsis is suspected, full blood count, clotting, renal function, liver function tests, c-reactive protein and arterial blood gas (to ascertain lactate level) should be taken. Low haemoglobin will reduce the delivery of oxygen to tissues so should be urgently identified and treated, while a raised white cell count is a strong indicator of infection and is used as part of the initial screening for sepsis. A raised lactate, though not specific to sepsis, provides clear evidence of metabolic compromise and development of severe sepsis.
Monitoring changes in lactate, and identifying improvement or deterioration, is linked to sepsis prognosis and is a good indicator of the impact of treatment.
Two sets of blood cultures are recommended to improve microbial identification and sensitivity and, therefore, antibiotic choice. Cultures should be taken from separate sites at the same time and should include one from each intravenous device in place for more than 48 hours. Cultures should also be taken from other sources, for example sputum or urine.
Fluid balance is a good indicator of circulating volume and renal function, and therefore essential for good sepsis management and the prevention of acute kidney injury. Insertion of a urinary catheter is the “gold-standard” for accurate measurement of urinary output but may increase infection risk.
Contrary to recent guidance for oxygen therapy (O’Driscoll et al, 2008), patients with sepsis need high-flow oxygen until there is clear evidence (from the blood gas) that no hypoperfusion exists. Careful consideration needs to be given to those with chronic lung disease who may not tolerate high levels of oxygen.
Fluid resuscitation is essential to prevent hypotension and improve cardiac output and therefore tissue perfusion. Many patients with sepsis are significantly dehydrated so high levels of fluid resuscitation are often needed. The SSC currently recommends 30ml/kg of crystalloids for patients with hypotension or raised lactate (>4mmol) (Dellinger et al, 2013). Lower volumes of fluid, given in intermittent boluses, should be considered in uncomplicated sepsis and reviewed regularly for efficacy. Lower volumes should also be considered for those with active heart or renal failure.
Broad-spectrum antibiotics should be given within one hour of sepsis being identified, having checked patient allergies. Antibiotic choice will depend on the probable source of infection, local policy and may involve discussion with microbiology. Antibiotic therapy should be reviewed daily to reduce toxicity, risk of resistance and cost (Dellinger et al, 2013).
It is essential to evaluate the response to treatment and an ongoing management plan. This should include level of observation, review schedule and an escalation plan. Clear escalation supports decision making for the whole team, setting out who should be contacted and when. A plan is needed for those who may not respond effectively and who need more invasive monitoring or intervention, usually provided in a high-dependency or intensive care environment. Treatment goals will be to optimise cardiac output measures, oxygenation and tissue perfusion and to measure the response to treatment.
Consideration needs to be given to those patients who are unlikely to respond to treatment and whose priority will be good end-of-life care. Open and frank discussions with the patient and family about treatment will help them understand the severity of the condition and its expected outcome.
Delivering all elements of Sepsis Six within one hour of identification sets a significant challenge in busy clinical areas. Similar to the “golden hour” described in good trauma, stroke or heart-attack care, teams need to coordinate roles and responsibilities so all elements of care are completed efficiently (Nguyen and Smith, 2006). The team lead should be responsible for the timeliness of interventions, clarifying roles and creating a plan of care, whether for referral, escalation or even end-of-life. Organisations have approached the work differently: some have created sepsis teams, others sepsis coordinators, or use tools that make reliable identification and treatment easier across all teams.
Sepsis care in the future
Sepsis prevalence is increasing, though it is unclear whether this is the result of better diagnosis or due to population change. The work of the SSC and other global forums has generated increasing interest in reducing the number of deaths caused by sepsis. With an ever-increasing workload and the introduction of healthcare-based targets, alongside staffing shortages and a lack of appropriate beds, there is much pressure on health staff to perform at higher levels of efficiency and to recognise patients who are potentially unwell or whose health is deteriorating while still providing high-quality care (McClelland, 2007).
Resources are now available for pre-hospital and community settings (Box 5), which will further improve timeliness of diagnosis and treatment. Research is aimed at finding blood markers that are sensitive to sepsis progression and effective treatments for severe sepsis and septic shock.
Sepsis is a leading cause of death and harm. Nurses are pivotal in spotting patients who are unwell or deteriorating, and in initiating life-saving treatments. Clear guidance on identification and evidence-based interventions is available to support effective and safe care. With the help of simple tools and robust escalation systems, it is possible for all staff to intervene early to prevent harm and significantly reduce mortality.
Bone RC et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest; 101: 6, 1644-1655.
Chege F, Cronin G (2007) Emergency care staff can improve survival rates from sepsis. Accident and Emergency Nurse; 15: 157-160.
Czura CJ (2011) Merinoff Symposium 2010: sepsis - speaking with one voice. Molecular Medicine; 17: 1-2, 2-3.
Daniels R (2011) Surviving the first hours in sepsis: getting the basics right (an intensivist’s perspective). Journal of Antimicrobial Chemotherapy; 66: 2, ii11-ii23.
Daniels R et al (2010) The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. Emergency Medicine Journal; 28: 507-512.
Dellinger RP et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Critical Care Medicine; 41: 2, 580-637.
Institute for Healthcare Improvement (2012) Using Care Bundles to Improve Health Care Quality.
McClelland H (2007) Can care bundles improve quality in emergency care? Accident and Emergency Nursing; 15: 119-120.
McNeill G et al (2008) Can acute medicine units in the UK comply with the Surviving Sepsis Campaign’s six-hour care bundle? Clinical Medicine; 8: 2, 163-165.
National Institute for Health and Clinical Excellence (2012) Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients. CG151.
Nguyen HB, Smith D (2006) Sepsis in the 21st century: recent definitions and therapeutic advances. American Journal of Emergency Medicine; 25, 564-571.
O’Driscoll BR et al (2008) On behalf of the British Thoracic Society. Guideline for emergency oxygen use in adult patients. Thorax; 63 (Suppl VI): vi1-vi68.
Porth MC (2005) Pathophysiology: Concepts of Altered Health States. Philadelphia PA: Lippincott Williams & Wilkins.
Royal College of Physicians (2012) National Early Warning Score (NEWS): Standardising the Assessment of Acute-illness Severity in the NHS.
Slade E et al (2003) The Surviving Sepsis Campaign: raising awareness to reduce mortality. Critical Care; 7, 1-2.
Survive Sepsis Organisation (2009) Survive Sepsis: The Official Educational Programme of the Surviving Sepsis Campaign. Sutton Coldfield: Survive Sepsis.
Woodrow P (2012) Intensive Care Nursing. London: Routledge.